FDA Approves Mavyret for Hepatitis C

Share this content:
FDA Approves Mavyret for Hepatitis C
FDA Approves Mavyret for Hepatitis C

FRIDAY, Aug. 4, 2017 (HealthDay News) -- Mavyret (glecaprevir and pibrentasvir) has been approved by the U.S. Food and Drug Administration to treat adults with certain types of chronic hepatitis C virus (HCV).

The combination drug is the first approved therapy for hepatitis C to require as few as eight weeks of treatment, the FDA said in a news release. Other therapies require treatment of 12 weeks or longer.

Mavyret was evaluated in clinical studies of some 2,300 adults with all six HCV genotypes. At least 92 percent of patients who took the drug had no HCV detected in the blood 12 weeks after completing treatment, the FDA said.

The most common side effects of the drug included headache, fatigue, and nausea. The drug shouldn't be taken by patients with cirrhosis, or by those taking the antiviral drugs atazanavir and rifampin. Patients who are simultaneously infected with hepatitis B virus should be monitored carefully while taking Mavyret, the agency added.

Approval for Mavyret was given to AbbVie Inc., based in Chicago.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Jury Awards 4.62B in Johnson  Johnson Talcum Powder Lawsuit

Jury Awards $4.62B in Johnson & Johnson Talcum ...

The award includes $550 million in compensatory damages and $4.14 billion in punitive damages

100 Now Sickened by Salmonella-Tainted Honey Smacks Cereal

100 Now Sickened by Salmonella-Tainted Honey Smacks Cereal

Thirty people have been hospitalized, but no deaths have been reported

Data Support FDA Restrictions on Child Cough and Cold Medicines

Data Support FDA Restrictions on Child Cough and ...

Surveillance data showed more adverse events for children exposed to hydrocodone than codeine

is free, fast, and customized just for you!




Already a member?

Sign In Now »